Estadístiques de Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis
Visites totals
| views | |
|---|---|
| Dual neoadjuvant blockade plus chemotherapy versus monotherapy for the treatment of women with non-metastatic HER2-positive breast cancer: a systematic review and meta-analysis | 88 |
Visites totals per mes
| views | |
|---|---|
| July 2024 | 0 |
| August 2024 | 20 |
| September 2024 | 27 |
| October 2024 | 0 |
| November 2024 | 1 |
| December 2024 | 0 |
| January 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| vazquez-cto-dual.pdf(legacy) | 170 |
| vazquez-cto-dual.pdf | 3 |
Vistes principals per país
| views | |
|---|---|
| United States | 64 |
| Australia | 7 |
| Belgium | 7 |
| China | 2 |
| Spain | 2 |
| Mongolia | 2 |
| Argentina | 1 |
| Germany | 1 |
| Ireland | 1 |
| India | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ann Arbor | 12 |
| Boardman | 10 |
| Menlo Park | 9 |
| Tustin | 5 |
| San Diego | 3 |
| Barcelona | 2 |
| Cambridge | 2 |
| Durham | 2 |
| Sükhbaatar | 2 |
| Andover | 1 |
| Fairfield | 1 |
| Inverloch | 1 |
| Kansas City | 1 |
| Mountain View | 1 |
| Pinjarra | 1 |
| Portland | 1 |
| Rochester | 1 |
| Shenzhen | 1 |
| Suipacha | 1 |
| Thane | 1 |